The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update
Open accessAbstract
To date, molecular genetic analyses have identified over 500 distinct DNA variants in five disease genes associated with familial Parkinson disease; alpha-synuclein (SNCA), parkin (PARK2), PTEN-induced putative kinase 1 (PINK1), DJ-1 (PARK7), and Leucine-rich repeat kinase 2 (LRRK2). These genetic variants include approximately 82% simple mutations and approximately 18% copy number variations. Some mutation subtypes are likely underestimated because only few studies reported extensive mutation analyses of all five genes, by both exonic sequencing and dosage analyses. Here we present an update of all mutations published to date in the literature, systematically organized in a novel mutation database (http://www.molgen.ua.ac.be/PDmutDB). In addition, we address the biological relevance of putative pathogenic mutations. This review emphasizes the need for comprehensive genetic screening of Parkinson patients followed by an insightful study of the functional relevance of observed genetic variants. Moreover, while capturing existing data from the literature it became apparent that several of the five Parkinson genes were also contributing to the genetic etiology of other Lewy Body Diseases and Parkinson-plus syndromes, indicating that mutation screening is recommendable in these patient groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026 · cited 2×
“In addition, parkin was shown to be recruited to dysfunctional mitochondria pointing toward a possible role of parkin in the induction of mitophagy [Narendra et al., 2008, 2009].”
BackgroundAlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 2×
“Mutations in PARK2 were reported to impair the E3 ubiquitin ligase activity of parkin [Shimura et al., 2000], which resulted in insufficient protein clearance and the subsequent formation of protein aggregates.”
BackgroundGenome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes
Davidson, W. S., Jonas, A., Clayton, D. F., & George, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9443 · Cited by 1,585
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,324
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228
Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010907200 · Cited by 1,096
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
The PINK1/Parkin pathway regulates mitochondrial morphology
Poole, A. C., Thomas, R. E., Andrews, L. A., McBride, H. M., Whitworth, A. J., & Pallanck, L. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709336105 · Cited by 885
The Mechanism of Ca2+-Dependent Regulation of Kinesin-Mediated Mitochondrial Motility
Wang, X., & Schwarz, T. L. (2009) · Cell · doi:10.1016/j.cell.2008.11.046 · Cited by 871
DJ‐1 has a role in antioxidative stress to prevent cell death
Taira, T., Saito, Y., Niki, T., Iguchi‐Ariga, S. M. M., Takahashi, K., & Ariga, H. (2004) · EMBO reports · doi:10.1038/sj.embor.7400074 · Cited by 853
Mapping of a gene for Parkinson's disease to chromosome 4q21-q23
Polymeropoulos, M. H., Higgins, J. J., Golbe, L. I., Johnson, W. G., Ide, S. E., Di Iorio, G., Sanges, G., Stenroos, E. S., Pho, L. T., Schaffer, A. A., et al. (1996) · Science · doi:10.1126/science.274.5290.1197 · Cited by 788 · cited 2×
“Apart from the Italian Contursi family, p.Ala53Thr was also identified in several families of Greek descent [Athanassiadou et al., 1999; Papadimitriou et al., 1999; Polymeropoulos et al., 1996, 1997; Spira et al., 2001].”
BackgroundA common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17830-1 · Cited by 774
Imai, Y., Soda, M., & Takahashi, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000447200 · Cited by 766
Deng, H., Dodson, M. W., Huang, H., & Guo, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803998105 · Cited by 689
Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D. S., Tabrizi, S. J., Wood, N. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.013 · Cited by 682
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M. P., Beilina, A., Blackinton, J., Thomas, K. J., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.001 · Cited by 671
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1
Funayama, M., Hasegawa, K., Kowa, H., Saito, M., Tsuji, S., & Obata, F. (2002) · Annals of Neurology · doi:10.1002/ana.10113 · Cited by 667
LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055509 · Cited by 665
THE BIOCHEMISTRY OF PARKINSON'S DISEASE
Cookson, M. R. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 664
Spira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 627
(2004) · doi:10.1002/ana.10846 · Cited by 614
PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1
Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050172 · Cited by 596
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
Strauss, K. M., Martins, L. M., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Müller, T., Bornemann, A., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi215 · Cited by 568
Kachergus, J., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 541
West, A. B., Moore, D. J., Choi, C., Andrabi, S. A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K.-L., Dawson, V. L., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl471 · Cited by 533
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
Di Fonzo, A., Rohé, C. F., Ferreira, J., Chien, H. F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17829-5 · Cited by 531
Abbas, N., Lucking, C. B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.567 · Cited by 530
Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin
Exner, N., Treske, B., Paquet, D., Holmström, K., Schiesling, C., Gispert, S., Carballo-Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0719-07.2007 · Cited by 513
Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease
Maraganore, D. M. (2006) · JAMA · doi:10.1001/jama.296.6.661 · Cited by 508
PINK1 mutations are associated with sporadic early‐onset parkinsonism
Valente, E. M., Salvi, S., Ialongo, T., Marongiu, R., Elia, A. E., Caputo, V., Romito, L., Albanese, A., Dallapiccola, B., & Bentivoglio, A. R. (2004) · Annals of Neurology · doi:10.1002/ana.20256 · Cited by 505
LRRK2 G2019S as a Cause of Parkinson's Disease in North African Arabs
Lesage, S., Dürr, A., Tazir, M., Lohmann, E., Leutenegger, A.-L., Janin, S., Pollak, P., & Brice, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055540 · Cited by 494
Valente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A., & Wood, N. W. (2001) · The American Journal of Human Genetics · doi:10.1086/319522 · Cited by 493
Lewy bodies and parkinsonism in families with parkin mutations
Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn‐Hardy, K., Petrucelli, L., Hussey, J., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1132 · Cited by 485
Characterization of PLA2G6 as a locus for dystonia‐parkinsonism
Paisan‐Ruiz, C., Bhatia, K. P., Li, A., Hernandez, D., Davis, M., Wood, N. W., Hardy, J., Houlden, H., Singleton, A., & Schneider, S. A. (2009) · Annals of Neurology · doi:10.1002/ana.21415 · Cited by 480
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1
Plun-Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., Harvey, K., Deas, E., Harvey, R. J., McDonald, N., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1644 · Cited by 479
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
Gloeckner, C. J., Kinkl, N., Schumacher, A., Braun, R. J., O'Neill, E., Meitinger, T., Kolch, W., Prokisch, H., & Ueffing, M. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi439 · Cited by 477
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
Nichols, W. C., Pankratz, N., Hernandez, D., Paisán-Ruíz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17828-3 · Cited by 457
Genomewide association study for susceptibility genes contributing to familial Parkinson disease
Pankratz, N., Wilk, J. B., Latourelle, J. C., DeStefano, A. L., Halter, C., Pugh, E. W., Doheny, K. F., Gusella, J. F., Nichols, W. C., Foroud, T., et al. (2009) · Human Genetics · doi:10.1007/s00439-008-0582-9 · Cited by 443
Pesah, Y., Pham, T., Burgess, H., Middlebrooks, B., Verstreken, P., Zhou, Y., Harding, M., Bellen, H., & Mardon, G. (2004) · Development · doi:10.1242/dev.01095 · Cited by 443
Phosphorylation of 4E‐BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
Imai, Y., Gehrke, S., Wang, H., Takahashi, R., Hasegawa, K., Oota, E., & Lu, B. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.163 · Cited by 430
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication
Fuchs, J., Nilsson, C., Kachergus, J., Munz, M., Larsson, E.-M., Schüle, B., Langston, J. W., Middleton, F. A., Ross, O. A., Hulihan, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000254458.17630.c5 · Cited by 397
Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation
Xiong, H., Wang, D., Chen, L., Choo, Y. S., Ma, H., Tang, C., Xia, K., Jiang, W., Ronai, Z., Zhuang, X., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37617 · Cited by 392
The role of pathogenic DJ‐1 mutations in Parkinson's disease
Abou‐Sleiman, P. M., Healy, D. G., Quinn, N., Lees, A. J., & Wood, N. W. (2003) · Annals of Neurology · doi:10.1002/ana.10675 · Cited by 383
PARK7, a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, on Chromosome 1p36
van Duijn, C. M., Dekker, M. C. J., Bonifati, V., Galjaard, R. J., Houwing-Duistermaat, J. J., Snijders, P. J. L. M., Testers, L., Breedveld, G. J., Horstink, M., Sandkuijl, L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/322996 · Cited by 379
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome
Fonzo, A. D., Dekker, M. C. J., Montagna, P., Baruzzi, A., Yonova, E. H., Guedes, L. C., Szczerbinska, A., Zhao, T., Dubbel-Hulsman, L. O. M., Wouters, C. H., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338144.10967.2b · Cited by 364
Spira, P. J., Sharpe, D. M., Halliday, G. M., Cavanagh, J., & Nicholson, G. A. (2001) · PubMed · Cited by 343
alpha-synuclein gene haplotypes are associated with Parkinson's disease
Farrer, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.17.1847 · Cited by 340
Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes
Bonifati, V., Rohé, C. F., Breedveld, G. J., Fabrizio, E., De Mari, M., Tassorelli, C., Tavella, A., Marconi, R., Nicholl, D. J., Chien, H. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167546.39375.82 · Cited by 338
Khan, N. L., Jain, S., Lynch, J. M., Pavese, N., Abou-Sleiman, P., Holton, J. L., Healy, D. G., Gilks, W. P., Sweeney, M. G., Ganguly, M., et al. (2005) · Brain · doi:10.1093/brain/awh667 · Cited by 317
Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease
Nishioka, K., Hayashi, S., Farrer, M. J., Singleton, A. B., Yoshino, H., Imai, H., Kitami, T., Sato, K., Kuroda, R., Tomiyama, H., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20753 · Cited by 316
Greggio, E., Zambrano, I., Kaganovich, A., Beilina, A., Taymans, J.-M., Daniëls, V., Lewis, P., Jain, S., Ding, J., Syed, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708718200 · Cited by 308
Hattori, N., Kitada, T., Matsumine, H., Asakawa, S., Yamamura, Y., Yoshino, H., Kobayashi, T., Yokochi, M., Wang, M., Yoritaka, A., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440612 · Cited by 296
Parkin mutations are frequent in patients with isolated early‐onset parkinsonism
Periquet, M., Latouche, M., Lohmann, E., Rawal, N., De Michele, G., Ricard, S., Teive, H., Fraix, V., Vidailhet, M., Nicholl, D., et al. (2003) · Brain · doi:10.1093/brain/awg136 · Cited by 292
Weihofen, A., Thomas, K. J., Ostaszewski, B. L., Cookson, M. R., & Selkoe, D. J. (2009) · Biochemistry · doi:10.1021/bi8019178 · Cited by 290
DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin
Mitsumoto, A., & Nakagawa, Y. (2001) · Free Radical Research · doi:10.1080/10715760100301381 · Cited by 287
The R1441C mutation of LRRK2 disrupts GTP hydrolysis
Lewis, P. A., Greggio, E., Beilina, A., Jain, S., Baker, A., & Cookson, M. R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.006 · Cited by 273
Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*
Berg, D., Schweitzer, K. J., Leitner, P., Zimprich, A., Lichtner, P., Belcredi, P., Brüssel, T., Schulte, C., Maass, S., Nägele, T., et al. (2005) · Brain · doi:10.1093/brain/awh666 · Cited by 261
PINK1-linked parkinsonism is associated with Lewy body pathology
Samaranch, L., Lorenzo-Betancor, O., Arbelo, J. M., Ferrer, I., Lorenzo, E., Irigoyen, J., Pastor, M. A., Marrero, C., Isla, C., Herrera-Henriquez, J., et al. (2010) · Brain · doi:10.1093/brain/awq051 · Cited by 258
α-Synuclein gene duplication is present in sporadic Parkinson disease
Ahn, T. B., Kim, S. Y., Kim, J. Y., Park, S. S., Lee, D. S., Min, H. J., Kim, Y. K., Kim, S. E., Kim, J. M., Kim, H. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000271080.53272.c7 · Cited by 249
Lewy body Parkinson's disease in a large pedigree with 77Parkin mutation carriers
Pramstaller, P. P., Schlossmacher, M. G., Jacques, T. S., Scaravilli, F., Eskelson, C., Pepivani, I., Hedrich, K., Adel, S., Gonzales-McNeal, M., Hilker, R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20587 · Cited by 247
Novel PINK1 mutations in early‐onset parkinsonism
Hatano, Y., Li, Y., Sato, K., Asakawa, S., Yamamura, Y., Tomiyama, H., Yoshino, H., Asahina, M., Kobayashi, S., Hassin‐Baer, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20251 · Cited by 245
Biochemical and pathological characterization of Lrrk2
Giasson, B. I., Covy, J. P., Bonini, N. M., Hurtig, H. I., Farrer, M. J., Trojanowski, J. Q., & Van Deerlin, V. M. (2006) · Annals of Neurology · doi:10.1002/ana.20791 · Cited by 238
Early‐onset Parkinson's disease caused by a compound heterozygous DJ‐1 mutation
Hague, S., Rogaeva, E., Hernandez, D., Gulick, C., Singleton, A., Hanson, M., Johnson, J., Weiser, R., Gallardo, M., Ravina, B., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10663 · Cited by 237
Multiple regions of α‐synuclein are associated with Parkinson's disease
Mueller, J. C., Fuchs, J., Hofer, A., Zimprich, A., Lichtner, P., Illig, T., Berg, D., Wüllner, U., Meitinger, T., & Gasser, T. (2005) · Annals of Neurology · doi:10.1002/ana.20438 · Cited by 234
Parkin-induced mitophagy in the pathogenesis of Parkinson disease
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2009) · Autophagy · doi:10.4161/auto.5.5.8505 · Cited by 231
Lrrk2 pathogenic substitutions in Parkinson's disease
Mata, I. F., Kachergus, J. M., Taylor, J. P., Lincoln, S., Aasly, J., Lynch, T., Hulihan, M. M., Cobb, S. A., Wu, R.-M., Lu, C.-S., et al. (2005) · Neurogenetics · doi:10.1007/s10048-005-0005-1 · Cited by 231
Li, X., Tan, Y., Poulose, S., Olanow, C. W., Huang, X., & Yue, Z. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04743.x · Cited by 230
Di Fonzo, A., Wu-Chou, Y.-H., Lu, C.-S., van Doeselaar, M., Simons, E. J., Rohé, C. F., Chang, H.-C., Chen, R.-S., Weng, Y.-H., Vanacore, N., et al. (2006) · Neurogenetics · doi:10.1007/s10048-006-0041-5 · Cited by 229
Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype
Klein, C., Pramstaller, P. P., Kis, B., Page, C. E., Kann, M., Leung, J., Woodward, H., Castellan, C. C., Scherer, M., Vieregge, P., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<65::aid-ana10>3.0.co;2-l · Cited by 228
Novel PINK1 mutations in early-onset parkinsonism
波田野, 靖. (2005) · Medical Entomology and Zoology · Cited by 227
Distribution, type, and origin of Parkin mutations: Review and case studies
Hedrich, K., Eskelson, C., Wilmot, B., Marder, K., Harris, J., Garrels, J., Meija‐Santana, H., Vieregge, P., Jacobs, H., Bressman, S. B., et al. (2004) · Movement Disorders · doi:10.1002/mds.20234 · Cited by 225
Moore, D. J., Zhang, L., Dawson, T. M., & Dawson, V. L. (2003) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2003.02265.x · Cited by 222
Zimprich, A., Müller-Myhsok, B., Farrer, M., Leitner, P., Sharma, M., Hulihan, M., Lockhart, P., Strongosky, A., Kachergus, J., Calne, D. B., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/380647 · Cited by 220
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease
Foroud, T., Uniacke, S. K., Liu, L., Pankratz, N., Rudolph, A., Halter, C., Shults, C., Marder, K., Conneally, P. M., Nichols, W. C., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000049470.00180.07 · Cited by 214
Parkin mutations and susceptibility alleles in late‐onset Parkinson's disease
Oliveira, S. A., Scott, W. K., Martin, E. R., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., Stern, M. B., Hiner, B. C., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10524 · Cited by 214
α‐Synuclein promoter confers susceptibility to Parkinson's disease
Pals, P., Lincoln, S., Manning, J., Heckman, M., Skipper, L., Hulihan, M., Van den Broeck, M., De Pooter, T., Cras, P., Crook, J., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20268 · Cited by 212
Self-citationHayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S., & Takahashi, H. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<884::aid-mds1019>3.0.co;2-8 · Cited by 212
Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease
Tang, B., Xiong, H., Sun, P., Zhang, Y., Wang, D., Hu, Z., Zhu, Z., Ma, H., Pan, Q., Xia, J.-H., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl104 · Cited by 212
Parkinsonism, Lrrk2 G2019S, and tau neuropathology
Rajput, A., Dickson, D. W., Robinson, C. A., Ross, O. A., Dächsel, J. C., Lincoln, S. J., Cobb, S. A., Rajput, M. L., & Farrer, M. J. (2006) · Neurology · doi:10.1212/01.wnl.0000240220.33950.0c · Cited by 211
Guo, L., Gandhi, P. N., Wang, W., Petersen, R. B., Wilson-Delfosse, A. L., & Chen, S. G. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.007 · Cited by 208
Mizuta, I., Satake, W., Nakabayashi, Y., Ito, C., Suzuki, S., Momose, Y., Nagai, Y., Oka, A., Inoko, H., Fukae, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl030 · Cited by 207
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia
Farrer, M. J., Stone, J. T., Lin, C.-H., Dächsel, J. C., Hulihan, M. M., Haugarvoll, K., Ross, O. A., & Wu, R.-M. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.12.001 · Cited by 205
Analysis of the PINK1 Gene in a Large Cohort of Cases With Parkinson Disease
Rogaeva, E., Johnson, J., Lang, A. E., Gulick, C., Gwinn-Hardy, K., Kawarai, T., Sato, C., Morgan, A., Werner, J., Nussbaum, R., et al. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1898 · Cited by 199
α‐Synuclein produces a long‐lasting increase in neurotransmitter release
Liu, S., Ninan, I., Antonova, I., Battaglia, F., Trinchese, F., Narasanna, A., Kolodilov, N., Dauer, W., Hawkins, R. D., & Arancio, O. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600451 · Cited by 198
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
Ross, O. A., Wu, Y., Lee, M., Funayama, M., Chen, M., Soto, A. I., Mata, I. F., Lee‐Chen, G., Chen, C. M., Tang, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21405 · Cited by 196
Goldwurm, S., Fonzo, A. D., Simons, E. J., Rohé, C. F., Zini, M., Canesi, M., Tesei, S., Zecchinelli, A., Antonini, A., Mariani, C., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.035568 · Cited by 195
Lücking, C., Abbas, N., Dürr, A., Bonifati, V, Bonnet, A.-M., de Broucker, T., De Michele, G., Wood, N., Agid, Y., & Brice, A. (1998) · The Lancet · doi:10.1016/s0140-6736(05)60746-5 · Cited by 188
Uversky, V. N., Lee, H.-J., Li, J., Fink, A. L., & Lee, S.-J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100551200 · Cited by 186
Hedrich, K., Djarmati, A., Schäfer, N., Hering, R., Wellenbrock, C., Weiss, P. H., Hilker, R., Vieregge, P., Ozelius, L. J., Heutink, P., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000113022.51739.88 · Cited by 185
Gwinn-Hardy, K., Mehta, N. D., Farrer, M., Maraganore, D., Muenter, M., Yen, S. H., Hardy, J., & Dickson, D. W. (2000) · Acta Neuropathologica · doi:10.1007/s004010051177 · Cited by 184
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa
Ibáñez, P., Lesage, S., Lohmann, E., Thobois, S., Michele, G. D., Borg, M., Agid, Y., Dürr, A., & Brice, A. (2006) · Brain · doi:10.1093/brain/awl005 · Cited by 182
Point Mutations (Thr240Arg and Ala311Stop) in theParkinGene
Hattori, N., Matsumine, H., Asakawa, S., Kitada, T., Yoshino, H., Elibol, B., Brookes, A. J., Yamamura, Y., Kobayashi, T., Wang, M., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9134 · Cited by 181
The PINK1–Parkin pathway is involved in the regulation of mitochondrial remodeling process
Park, J., Lee, G., & Chung, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.086 · Cited by 180
LRRK2 gene in Parkinson disease: Mutation analysis and case control association study
Paisán-Ruíz, C., Lang, A. E., Kawarai, T., Sato, C., Salehi-Rad, S., Fisman, G. K., Al-Khairallah, T., St George-Hyslop, P., Singleton, A., & Rogaeva, E. (2005) · Neurology · doi:10.1212/01.wnl.0000167552.79769.b3 · Cited by 178
Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson Disease
Lautier, C., Goldwurm, S., Dürr, A., Giovannone, B., Tsiaras, W. G., Pezzoli, G., Brice, A., & Smith, R. J. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.015 · Cited by 178
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease
The Italian Parkinson Genetics Network, Di Fonzo, A., Tassorelli, C., De Mari, M., Chien, H. F., Ferreira, J., Rohé, C. F., Riboldazzi, G., Antonini, A., Albani, G., et al. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201539 · Cited by 174
DJ‐1 mutations and parkinsonism‐dementia‐amyotrophic lateral sclerosis complex
Annesi, G., Savettieri, G., Pugliese, P., D'Amelio, M., Tarantino, P., Ragonese, P., La Bella, V., Piccoli, T., Civitelli, D., Annesi, F., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20666 · Cited by 173
Ibáñez, P., Lesage, S., Janin, S., Lohmann, E., Durif, F., Destée, A., Bonnet, A.-M., Brefel‐Courbon, C., Heath, S. C., Zélénika, D., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.555 · Cited by 173
A heterozygous effect for PINK1 mutations in Parkinson's disease?
Abou‐Sleiman, P. M., Muqit, M. M. K., McDonald, N. Q., Yang, Y. X., Gandhi, S., Healy, D. G., Harvey, K., Harvey, R. J., Deas, E., Bhatia, K., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20960 · Cited by 166
Sun, M., Latourelle, J. C., Wooten, G. F., Lew, M., Klein, C., Shill, H. A., Golbe, L. I., Mark, M. H., Racette, B. A., Perlmutter, J. S., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.6.826 · Cited by 164
The LRRK2 Gly2385Arg variant is associated with Parkinson’s disease: genetic and functional evidence
Tan, E. K., Zhao, Y., Skipper, L., Tan, M. G., Di Fonzo, A., Sun, L., Fook-Chong, S., Tang, S., Chua, E., Yuen, Y., et al. (2007) · Human Genetics · doi:10.1007/s00439-006-0268-0 · Cited by 160
Leroy, E., Anastasopoulos, D., Konitsiotis, S., Lavedan, C., & Polymeropoulos, M. H. (1998) · Human Genetics · doi:10.1007/s004390050845 · Cited by 159
Gotthardt, K., Weyand, M., Kortholt, A., Van Haastert, P. J. M., & Wittinghofer, A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.150 · Cited by 159
Evaluation of 50 probands with early-onset Parkinson’s disease for Parkin mutations
Hedrich, K., Marder, K. S., Harris, J. M., Kann, M., Lynch, T., Meija‐Santana, H., Pramstaller, P. P., SCHWINGER, E., Bressman, S., Fahn, S., et al. (2002) · Neurology · doi:10.1212/wnl.58.8.1239 · Cited by 155
The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease
Orr‐Urtreger, A., Shifrin, C., Rozovski, U., Rosner, S., Bercovich, D., Gurevich, T., Yagev-More, H., Bar‐Shira, A., & Giladi, N. (2007) · Neurology · doi:10.1212/01.wnl.0000277637.33328.d8 · Cited by 155
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
Haugarvoll, K., Rademakers, R., Kachergus, J. M., Nuytemans, K., Ross, O. A., Gibson, J. M., Tan, E., Gaig, C., TOLOSA, E. S., Goldwurm, S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000304044.22253.03 · Cited by 154
Self-citationLiu, W., Vives-Bauzá, C., Acín‐Pérez, R., Yamamoto, A., Tan, Y.-C., Li, Y., Magrané, J., Stavarache, M. A., Shaffer, S., Chang, S. H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004597 · Cited by 154
Patients Homozygous and Heterozygous for SNCA Duplication in a Family With Parkinsonism and Dementia
Ikeuchi, T., Kakita, A., Shiga, A., Kasuga, K., Kaneko, H., Tan, C., Idezuka, J., Wakabayashi, K., Onodera, O., Iwatsubo, T., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.514 · Cited by 154
Hedrich, K. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1649 · Cited by 153
LRRK2 mutations in Parkinson disease
Farrer, M. J., Stone, J., Mata, I. F., Lincoln, S. J., Kachergus, J. M., Hulihan, M., Strain, K. J., & Maraganore, D. M. (2005) · Neurology · doi:10.1212/01.wnl.0000169023.51764.b0 · Cited by 153
A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations
Zabetian, C. P., Samii, A., Mosley, A. D., Roberts, J. W., Leis, B. C., Yearout, D., Raskind, W. H., & Griffith, A. (2005) · Neurology · doi:10.1212/01.wnl.0000172630.22804.73 · Cited by 150
Expanding the clinical phenotype of SNCA duplication carriers
Nishioka, K., Ross, O. A., Ishii, K., Kachergus, J. M., Ishiwata, K., Kitagawa, M., Kono, S., Obi, T., Mizoguchi, K., Inoue, Y., et al. (2009) · Movement Disorders · doi:10.1002/mds.22682 · Cited by 147
Sim, C. H., Lio, D. S. S., Mok, S. S., Masters, C. L., Hill, A. F., Culvenor, J. G., & Cheng, H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl398 · Cited by 147
α-Synuclein and Parkinson disease susceptibility
Winkler, S., Hagenah, J., Lincoln, S. J., Heckman, M. G., Haugarvoll, K., Lohmann-Hedrich, K., Kostić, V., Farrer, M. J., & Klein, C. (2007) · Neurology · doi:10.1212/01.wnl.0000275524.15125.f4 · Cited by 142
Role of parkin mutations in 111 community‐based patients with early‐onset parkinsonism
Kann, M., Jacobs, H., Mohrmann, K., Schumacher, K., Hedrich, K., Garrels, J., Wiegers, K., SCHWINGER, E., Pramstaller, P. P., Breakefield, X. O., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10179 · Cited by 141
Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism
Li, Y., Tomiyama, H., Sato, K., Hatano, Y., Yoshino, H., Atsumi, M., Kitaguchi, M., Sasaki, S., Kawaguchi, S., Miyajima, H., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000164009.36740.4e · Cited by 138
Hedrich, K., Hagenah, J. M., Djarmati, A., Hiller, A., Lohnau, T., Lasek, K., Grünewald, A., Hilker, R., Steinlechner, S., Boston, H., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.6.833 · Cited by 133
Mutated α-synuclein gene in two Greek kindreds with familial PD: Incomplete penetrance?
Papadimitriou, A., Veletza, V., Hadjigeorgiou, G. M., Patrikiou, A., Hirano, M., & Anastasopoulos, I. (1999) · Neurology · doi:10.1212/wnl.52.3.651 · Cited by 132
PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism
Klein, C., Djarmati, A., Hedrich, K., Schäfer, N., Scaglione, C. L. M., Marchese, R., Kock, N., Schüle, B., Hiller, A., Lohnau, T., et al. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201455 · Cited by 131
Investigation of leucine‐rich repeat kinase 2: Enzymological properties and novel assays
Anand, V. S., Reichling, L. J., Lipinski, K., Stochaj, W. R., Duan, W., Kelleher, K. S., Pungaliya, P., Brown, E. L., Reinhart, P. H., Somberg, R. L., et al. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06789.x · Cited by 127
Autosomal dominant Lewy body parkinsonism in a four‐generation family
Waters, C., & Miller, C. A. (1994) · Annals of Neurology · doi:10.1002/ana.410350110 · Cited by 127
Athanassiadou, A., Voutsinas, G. E., Psiouri, L., Leroy, E., Polymeropoulos, M. H., Ilias, A., Maniatis, G. M., & Papapetropoulos, T. (1999) · The American Journal of Human Genetics · doi:10.1086/302486 · Cited by 126
Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism
Rohé, C. F., Montagna, P., Breedveld, G. J., Cortelli, P., Oostra, B. A., & Bonifati, V. (2004) · Annals of Neurology · doi:10.1002/ana.20247 · Cited by 126
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7)
Hering, R., Strauss, K. M., Tao, X., Bauer, A., Woitalla, D., Mietz, E.-M., Petrovic, S., Bauer, P., Schaible, W., Müller, T. H., et al. (2004) · Human Mutation · doi:10.1002/humu.20089 · Cited by 123
LRRK2 Mutations in Spanish Patients With Parkinson Disease
Gaig, C., Ezquerra, M., Martı́, M. J., Muñoz, E., Valldeoriola, F., & TOLOSA, E. S. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.377 · Cited by 123
Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients
Kay, D. M., Moran, D., Moses, L., Poorkaj, P., Zabetian, C. P., Nutt, J. G., Factor, S. A., Yu, C., Montimurro, J. S., Keefe, R. G., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21039 · Cited by 116
Parkin-positive autosomal recessive juvenile parkinsonism with α-synuclein-positive inclusions
Sasaki, S., Shirata, A., Yamane, K., & Iwata, M. (2004) · Neurology · doi:10.1212/01.wnl.0000134657.25904.0b · Cited by 114
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
Gaig, C., Martı́, M. J., Ezquerra, M., Rey, M. J., Cardozo, A., & TOLOSA, E. S. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.107904 · Cited by 112
PARK6-linked parkinsonism occurs in several European families.
Valente, E. M., Brancati, F., Ferraris, A., Graham, E. A., Davis, M. B., Breteler, M. M. B., Gasser, T., Bonifati, V., Bentivoglio, A. R., Michele, G. D., et al. (2002) · PubMed · Cited by 110
Periquet, M., Lücking, C. B., Vaughan, J. R., Bonifati, V., Dürr, A., Michele, G. D., Horstink, M. W. I. M., Farrer, M. J., Illarioshkin, S. N., Pollak, P., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318791 · Cited by 109
PINK1 (PARK6) associated Parkinson disease in Ireland
Healy, D. G., Abou‐Sleiman, P. M., Gibson, J. M., Ross, O. A., Jain, S., Gandhi, S., Gosal, D. Y., Muqit, M. M. K., Wood, N. W., & Lynch, T. (2004) · Neurology · doi:10.1212/01.wnl.0000142089.38301.8e · Cited by 109
Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries
Tomiyama, H., Li, Y., Funayama, M., Hasegawa, K., Yoshino, H., Kubo, S., Sato, K., Hattori, T., Lu, C., Inzelberg, R., et al. (2006) · Movement Disorders · doi:10.1002/mds.20886 · Cited by 109
Paisán‐Ruiz, C., Nath, P., Washecka, N., Gibbs, J. R., & Singleton, A. (2008) · Human Mutation · doi:10.1002/humu.20668 · Cited by 108
Scherfler, C., Khan, N. L., Pavese, N., Eunson, L., Graham, E., Lees, A. J., Quinn, N. P., Wood, N. W., Brooks, D. J., & Piccini, P. P. (2004) · Brain · doi:10.1093/brain/awh150 · Cited by 108
Park6‐linked parkinsonism occurs in several european families
Valente, E. M., Brancati, F., Ferraris, A., Graham, E. A., Davis, M. B., Breteler, M. M. B., Gasser, T., Bonifati, V., Bentivoglio, A. R., Michele, G. D., et al. (2001) · Annals of Neurology · doi:10.1002/ana.10053 · Cited by 107
PINK1 mutations in sporadic early‐onset Parkinson's disease
Tan, E., Yew, K., Chua, E., Puvan, K., Shen, H., Lee, E., Puong, K., Zhao, Y., Ratnagopal, P., Wong, M. C., et al. (2006) · Movement Disorders · doi:10.1002/mds.20810 · Cited by 105
A Swedish family with de novo α-synuclein A53T mutation: Evidence for early cortical dysfunction
Puschmann, A., Ross, O. A., Vilariño‐Güell, C., Lincoln, S., Kachergus, J. M., Cobb, S. A., Lindquist, S. G., Nielsen, J. E., Wszołek, Z. K., Farrer, M. J., et al. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.06.007 · Cited by 105
Latourelle, J. C., Sun, M., Lew, M., Suchowersky, O., Klein, C., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., Watts, R. L., et al. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-32 · Cited by 105
Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease
Choi, J. M., Woo, M. S., Ma, H., Kang, S. Y., Sung, Y. H., Yong, S. W., Chung, S. J., Kim, J., Shin, H., Lyoo, C. H., et al. (2008) · Neurogenetics · doi:10.1007/s10048-008-0138-0 · Cited by 101
Wang, H., Chou, A.-H., Yeh, T., Li, A. H.-L., Chen, Y., Kuo, Y.-L., Tsai, S.-R., & Yu, S.-T. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.010 · Cited by 99
LRRK2 R1441G in Spanish patients with Parkinson's disease
Mata, I. F., Taylor, J. P., Kachergus, J. M., Hulihan, M., Huerta, C., Lahoz, C., Estrada, M. B., Guisasola, L. M., Salvador, C., Ribacoba, R., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.033 · Cited by 98
Hernandez, D. G., Ruiz, C. P., Crawley, A., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.044 · Cited by 98
DJ-1 protects against dopamine toxicity
Lev, N., Ickowicz, D., Barhum, Y., Lev, S., Melamed, E., & Offen, D. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0134-4 · Cited by 96
Parkinson's disease due to the R1441G mutation in Dardarin: A founder effect in the basques
Simón‐Sánchez, J., Martí-Massó, J. F., Sanchez-Mut, J. V., Paisán‐Ruiz, C., Martínez-Gil, Á., Ruiz‐Martínez, J., Sáenz, A., Singleton, A., de Munaín, A. L., & Pérez‐Tur, J. (2006) · Movement Disorders · doi:10.1002/mds.21114 · Cited by 94
Brooks, J. A., Ding, J., Simón‐Sánchez, J., Paisán‐Ruiz, C., Singleton, A., & Scholz, S. W. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.063917 · Cited by 94
Maruyama, M., Ikeuchi, T., Saito, M., Ishikawa, A., Yuasa, T., Tanaka, H., Hayashi, S., Wakabayashi, K., Takahashi, H., & Tsuji, S. (2000) · Annals of Neurology · Cited by 89
Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease
Macedo, M. G., Verbaan, D., Fang, Y., van Rooden, S. M., Jeukens‐Visser, M., Anar, B., Uras, A., Groen, J. L., Rizzu, P., van Hilten, J. J., et al. (2008) · Movement Disorders · doi:10.1002/mds.22287 · Cited by 87
Polymorphism in theparkin gene in sporadic Parkinson's disease
Wang, M., Hattori, N., Matsumine, H., Kobayashi, T., Yoshino, H., Morioka, A., Kitada, T., Asakawa, S., Minoshima, S., Shimizu, N., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<655::aid-ana15>3.0.co;2-g · Cited by 87
Mutation Analysis of the PINK1 Gene in 391 Patients With Parkinson Disease
Kumazawa, R., Tomiyama, H., Li, Y., Imamichi, Y., Funayama, M., Yoshino, H., Yokochi, F., Fukusako, T., Takehisa, Y., Kashihara, K., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.6.802 · Cited by 86
Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation
Bostantjopoulou, S., Katsarou, Z., Papadimitriou, A., Veletza, V., Hatzigeorgiou, G., & Lees, A. J. (2001) · Movement Disorders · doi:10.1002/mds.1221 · Cited by 85
Case-Control Study of the Parkin Gene in Early-Onset Parkinson Disease
Clark, L. N., Afridi, S., Karlins, E., Wang, Y., Mejia‐Santana, H., Harris, J. M., Louis, E. D., COTE, L. J., Andrews, H., Fahn, S., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.548 · Cited by 85
CLINICOPATHOLOGIC STUDY OF A SNCA GENE DUPLICATION PATIENT WITH PARKINSON DISEASE AND DEMENTIA
Obi, T., Nishioka, K., Ross, O. A., Terada, T., Yamazaki, K., Sugiura, A., Takanashi, M., Mizoguchi, K., Mori, H., Mizuno, Y., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000299387.59159.db · Cited by 85
Alpha-synuclein haplotypes implicated in risk of Parkinson’s disease
Tan, E., Chai, A., Teo, Y., Zhao, Y., Tan, C. E., Shen, H., Chandran, V. R., Teoh, M. L., Yih, Y., Pavanni, R., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000101721.25345.dc · Cited by 82
Gorostidi, A., Ruiz‐Martínez, J., de Munaín, A. L., Alzualde, A., & Martí-Massó, J. F. (2008) · Neurogenetics · doi:10.1007/s10048-008-0162-0 · Cited by 81
Analysis of an early‐onset Parkinson's disease cohort for DJ‐1 mutations
Clark, L. N., Afridi, S. K., Mejia‐Santana, H., Harris, J. M., Louis, E. D., COTE, L. J., Andrews, H., Singleton, A., DeVriéze, F. W., Hardy, J., et al. (2004) · Movement Disorders · doi:10.1002/mds.20131 · Cited by 80
High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal
Ferreira, J. J., Guedes, L. C., Rosa, M. M., Coelho, M. M., van Doeselaar, M., Schweiger, D., Fonzo, A. D., Oostra, B. A., Sampaio, C., & Bonifati, V. (2007) · Movement Disorders · doi:10.1002/mds.21525 · Cited by 79
PINK1heterozygous rare variants: prevalence, significance and phenotypic spectrum
Marongiu, R., Ferraris, A., Ialongo, T., Michiorri, S., Soleti, F., Ferrari, F., Elia, A. E., Ghezzi, D., Albanese, A., Altavista, M. C., et al. (2008) · Human Mutation · doi:10.1002/humu.20719 · Cited by 78
LRRK2gene variation and its contribution to Parkinson disease
Paisán‐Ruiz, C. (2009) · Human Mutation · doi:10.1002/humu.21038 · Cited by 78
Novel human pathological mutations
Lewis, P. D. (2006) · Human Genetics · doi:10.1007/s00439-005-0109-6 · Cited by 76
Whole gene deletion and splicing mutations expand thePINK1 genotypic spectrum
Marongiu, R., Brancati, F., Antonini, A., Ialongo, T., Ceccarini, C., Scarciolla, O., Capalbo, A., Benti, R., Pezzoli, G., Dallapiccola, B., et al. (2006) · Human Mutation · doi:10.1002/humu.9472 · Cited by 76
An, X., Peng, R., Li, T., et al. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.02052.x · Cited by 76
Escaping Parkinson's disease: A neurologically healthy octogenarian with the LRRK2 G2019S mutation
Kay, D. M., Kramer, P., Higgins, D. S., Zabetian, C. P., & Payami, H. (2005) · Movement Disorders · doi:10.1002/mds.20618 · Cited by 76
Analysis of LRRK2 functional domains in nondominant Parkinson disease
Skipper, L. M., Shen, H., Chua, E., Bonnard, C., Kolatkar, P. R., Tan, L. C. S., Jamora, R. D. G., Puvan, K., Puong, K. Y., Zhao, Y., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000180517.70572.37 · Cited by 75
Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism
Moro, E., Volkmann, J., König, I. R., Winkler, S., Hiller, A., Hassin‐Baer, S., Herzog, J., Schnitzler, A., Lohmann, K., Pinsker, M. O., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000307748.11216.03 · Cited by 74
Myhre, R., Toft, M., Kachergus, J. M., Hulihan, M., Aasly, J. O., Klungland, H., & Farrer, M. J. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01019.x · Cited by 74
The Ala53Thr mutation in the α‐synuclein gene in a Korean family with Parkinson disease
Ki, C., Stavrou, E., Davanos, Ν., Lee, W., Chung, E., Kim, J., & Athanassiadou, A. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00781.x · Cited by 73
Nuytemans, K., Meeus, B., Crosiers, D., Brouwers, N., Goossens, D., Engelborghs, S., Pals, P., Pickut, B. A., den Broeck, M. V., Corsmit, E., et al. (2009) · Human Mutation · doi:10.1002/humu.21007 · Cited by 73
Self-citationBentivoglio, A. R., Cortelli, P., Valente, E. M., Ialongo, T., Ferraris, A., Elia, A. E., Montagna, P., & Albanese, A. (2001) · Movement Disorders · doi:10.1002/mds.10034 · Cited by 71
Okubadejo, N. U., Britton, A. F., Crews, C. K., Akinyemi, R., Hardy, J., Singleton, A., & Brás, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003421 · Cited by 71
Camargos, S., de Oliveira, L. D., Momeni, P., Lees, A. J., Hardy, J., Singleton, A., & Cardoso, F. (2009) · Movement Disorders · doi:10.1002/mds.22365 · Cited by 70
Ephraty, L., Porat, O., Israeli, D., Cohen, O. S., Tunkel, O., Shinar, Y., Hatano, Y., Hattori, N., & Hassin‐Baer, S. (2007) · Movement Disorders · doi:10.1002/mds.21319 · Cited by 70
Genetic studies in Parkinson's disease with an α-synuclein/NACP gene polymorphism in Japan
Izumi, Y., Morino, H., Oda, M., Maruyama, H., Udaka, F., Kameyama, M., Nakamura, S., & Kawakami, H. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01557-9 · Cited by 68
Parkin Mutations and Early-Onset Parkinsonism in a Taiwanese Cohort
Wu, R., Bounds, R., Lincoln, S., Hulihan, M., Lin, C., Hwu, W., Chen, J., Gwinn, K. A., & Farrer, M. J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.1.82 · Cited by 68
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8
Nichols, W. C., Elsaesser, V. E., Pankratz, N., Pauciulo, M. W., Marek, D. K., Halter, C. A., Rudolph, A., Shults, C. W., & Foroud, T. (2007) · Neurology · doi:10.1212/01.wnl.0000278115.50741.4e · Cited by 67
Guo, J., Xiao, B., Liao, B., Zhang, X., Nie, L.-L., Zhang, Y., Shen, L. H., Jiang, H. F., Xia, K., Pan, Q., et al. (2008) · Movement Disorders · doi:10.1002/mds.22156 · Cited by 66
Novel parkin mutations detected in patients with early‐onset Parkinson's disease
Bertoli‐Avella, A. M., Giroud‐Benitez, J. L., Akyol, A., Barbosa, E. R., Schaap, O., van der Linde, H. C., Martignoni, E., Lopiano, L., Lamberti, P., Fincati, E., et al. (2004) · Movement Disorders · doi:10.1002/mds.20343 · Cited by 66
Genetic association between α‐synuclein and idiopathic parkinson's disease
Kay, D. M., Factor, S. A., Samii, A., Higgins, D. S., Griffith, A., Roberts, J. W., Leis, B. C., Nutt, J. G., Montimurro, J. S., Keefe, R. G., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30758 · Cited by 66
LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease
Zabetian, C. P., Yamamoto, M., Lopez, A. N., Ujike, H., Mata, I. F., Izumi, Y., Kaji, R., Maruyama, H., Morino, H., Oda, M., et al. (2009) · Movement Disorders · doi:10.1002/mds.22514 · Cited by 64
New mutation (R42P) of the parkin gene in the ubiquitinlike domain associated with parkinsonism
Terreni, L., Calabrese, E., Calella, A. M., Forloni, G., & Mariani, C. (2001) · Neurology · doi:10.1212/wnl.56.4.463 · Cited by 64
Central Role of α-Synuclein Oligomers in Neurodegeneration in Parkinson Disease
Kazantsev, A. G., & Kolchinsky, A. M. (2008) · Archives of Neurology · doi:10.1001/archneur.65.12.1577 · Cited by 64
Cited by
Genetics of Parkinson's Disease
Klein, C., & Westenberger, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008888 · Cited by 1,358
Human iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
Prusiner, S. B., Woerman, A. L., Mordes, D. A., Watts, J. C., Rampersaud, R., Berry, D. B., Patel, S., Oehler, A., Lowe, J. K., Kravitz, S. N., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514475112 · Cited by 689
Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 642
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 611
Metadata
- Authors
- Nuytemans, K., Theuns, J., Cruts, M., & Van Broeckhoven, C.
- Venue
- Human Mutation
- Publisher
- Wiley
- Published
- 2010-05-18
- Volume
- 31
- Issue
- 7
- Pages
- 763-780
- ISSN
- 1059-7794 (ISSN-L)
- OpenAlex
- W2042062646
- Cited by
- 563
- References
- 274
- FWCI
- 24.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.